Tapewire

Nasdaq · USD

TNDM

TANDEM DIABETES CARE INC

Export transactions ↓
Tapewire entity
4682
SEC CIK
0001438133
Parsed reports
672

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 29, 2020 Filed Jan 31, 2020 22:22 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 48,512 $75.91 $3,682,545.92
Disclosure

SEC source: 0001438133-20-000006 · wf-form4_158050930804263.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 643,238

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $75.29 and $76.25.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
January 29, 2020 Filed Feb 3, 2020 18:00 UTC Amendment
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 1,488 $76.33 $113,579.04
Disclosure

SEC source: 0001438133-20-000010 · wf-form4a_158075284094251.xml · nonDerivative · entry 2

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 641,750

F1 · kind: This amendment is being filed to reflect that the sale was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person dated March 11, 2019.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $76.28 and $76.54.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
January 29, 2020 Filed Feb 3, 2020 18:00 UTC Amendment
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 48,512 $75.91 $3,682,545.92
Disclosure

SEC source: 0001438133-20-000010 · wf-form4a_158075284094251.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 643,238

F1 · kind: This amendment is being filed to reflect that the sale was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person dated March 11, 2019.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $75.29 and $76.25.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
January 16, 2020 Filed Jan 17, 2020 23:59 UTC
BERGER DAVID BEVP, Chief Legal & Compliance
Exercise / conversionStock Option · Derivative 8,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001438133-20-000004 · wf-form4_157930556999366.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Stock Option · 8,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
January 16, 2020 Filed Jan 17, 2020 23:59 UTC
BERGER DAVID BEVP, Chief Legal & Compliance
SaleCommon Stock 8,000 $67.83 $542,640.00
Disclosure

SEC source: 0001438133-20-000004 · wf-form4_157930556999366.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,311

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.

Read SEC document
January 16, 2020 Filed Jan 17, 2020 23:59 UTC
BERGER DAVID BEVP, Chief Legal & Compliance
Exercise / conversionCommon Stock 8,000 $2.59 $20,720.00
Disclosure

SEC source: 0001438133-20-000004 · wf-form4_157930556999366.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,311

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
January 16, 2020 Filed Jan 17, 2020 23:57 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001438133-20-000002 · wf-form4_157930543731668.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equalmonthly installments thereafter.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
January 16, 2020 Filed Jan 17, 2020 23:57 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
SaleCommon Stock 10,000 $69.76 $697,620.00
Disclosure

SEC source: 0001438133-20-000002 · wf-form4_157930543731668.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,991

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $69.76 and $69.77.

Read SEC document
January 16, 2020 Filed Jan 17, 2020 23:57 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001438133-20-000002 · wf-form4_157930543731668.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,991

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:26 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 36,738 $60.60 $2,226,322.80
Disclosure

SEC source: 0001438133-19-000032 · wf-form4_157670436312591.xml · nonDerivative · entry 5

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 691,750

F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $60.13 and $61.09.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:26 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 27,327 $59.54 $1,627,049.58
Disclosure

SEC source: 0001438133-19-000032 · wf-form4_157670436312591.xml · nonDerivative · entry 4

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 728,488

F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $59.13 and $60.10.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:26 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 35,935 $58.79 $2,112,618.65
Disclosure

SEC source: 0001438133-19-000032 · wf-form4_157670436312591.xml · nonDerivative · entry 3

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 755,815

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $58.13 and $59.12.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:26 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 25,000 $60.93 $1,523,250.00
Disclosure

SEC source: 0001438133-19-000032 · wf-form4_157670436312591.xml · nonDerivative · entry 2

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 791,750

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $60.70 and $61.10.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:26 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 75,000 $59.75 $4,481,250.00
Disclosure

SEC source: 0001438133-19-000032 · wf-form4_157670436312591.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 816,750

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $59.50 and $60.33.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
November 25, 2019 Filed Nov 27, 2019 00:38 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001438133-19-000026 · wf-form4_157481507469736.xml · derivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
November 25, 2019 Filed Nov 27, 2019 00:38 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
SaleCommon Stock 10,000 $70.35 $703,500.00
Disclosure

SEC source: 0001438133-19-000026 · wf-form4_157481507469736.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,265

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person March 7, 2019, as amended on August 26, 2019.

F3 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $70.91. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
November 25, 2019 Filed Nov 27, 2019 00:38 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 10,000 $2.59 $25,900.00
Disclosure

SEC source: 0001438133-19-000026 · wf-form4_157481507469736.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
November 25, 2019 Filed Nov 27, 2019 00:36 UTC
Sheridan John FPRESIDENT & CEO
Exercise / conversionStock Option · Derivative 462 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001438133-19-000025 · wf-form4_157481499716966.xml · derivative · entry 3

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,667

Underlying: Common Stock · 462 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
November 25, 2019 Filed Nov 27, 2019 00:36 UTC
Sheridan John FPRESIDENT & CEO
SaleCommon Stock 462 $70.00 $32,340.00
Disclosure

SEC source: 0001438133-19-000025 · wf-form4_157481499716966.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,501

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 6, 2019.

Read SEC document
November 25, 2019 Filed Nov 27, 2019 00:36 UTC
Sheridan John FPRESIDENT & CEO
Exercise / conversionCommon Stock 462 $2.59 $1,196.58
Disclosure

SEC source: 0001438133-19-000025 · wf-form4_157481499716966.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,963

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
November 18, 2019 Filed Nov 19, 2019 00:12 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionStock Option · Derivative 10,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001438133-19-000022 · wf-form4_157412235717003.xml · derivative · entry 5

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
November 18, 2019 Filed Nov 19, 2019 00:12 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
SaleCommon Stock 1,700 $66.11 $112,387.00
Disclosure

SEC source: 0001438133-19-000022 · wf-form4_157412235717003.xml · nonDerivative · entry 3

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,265

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2019, as amended on August 26, 2019.

F4 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $66.07 to $66.15. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
November 18, 2019 Filed Nov 19, 2019 00:12 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
SaleCommon Stock 8,300 $65.27 $541,741.00
Disclosure

SEC source: 0001438133-19-000022 · wf-form4_157412235717003.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,965

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2019, as amended on August 26, 2019.

F3 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $65.00 to $65.74. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
November 18, 2019 Filed Nov 19, 2019 00:12 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 10,000 $2.59 $25,900.00
Disclosure

SEC source: 0001438133-19-000022 · wf-form4_157412235717003.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: . Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
November 04, 2019 Filed Nov 6, 2019 22:13 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionStock Option · Derivative 15,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001438133-19-000020 · wf-form4_157307838319846.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equalmonthly installments thereafter.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
November 04, 2019 Filed Nov 6, 2019 22:13 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
SaleCommon Stock 15,000 $62.01 $930,130.50
Disclosure

SEC source: 0001438133-19-000020 · wf-form4_157307838319846.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,991

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018 and amended on May 16,2019.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $61.75 and$62.26.

Read SEC document
November 04, 2019 Filed Nov 6, 2019 22:13 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 15,000 $2.59 $38,850.00
Disclosure

SEC source: 0001438133-19-000020 · wf-form4_157307838319846.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,991

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2019 Filed Sep 9, 2019 20:20 UTC
Sheridan John FPRESIDENT & CEO
Exercise / conversionStock Option · Derivative 9,538 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001209191-19-048892 · doc4.xml · derivative · entry 3

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,129

Underlying: Common Stock · 9,538 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter

F5 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant.

Read SEC document
September 06, 2019 Filed Sep 9, 2019 20:20 UTC
Sheridan John FPRESIDENT & CEO
SaleCommon Stock 9,538 $70.03 $667,946.14
Disclosure

SEC source: 0001209191-19-048892 · doc4.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,501

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2019.

F3 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $70.05. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
September 06, 2019 Filed Sep 9, 2019 20:20 UTC
Sheridan John FPRESIDENT & CEO
Exercise / conversionCommon Stock 9,538 $2.59 $24,703.42
Disclosure

SEC source: 0001209191-19-048892 · doc4.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
September 03, 2019 Filed Sep 3, 2019 23:27 UTC
BERGER DAVID BEVP, Chief Legal & Compliance
Exercise / conversionStock Option · Derivative 2,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001209191-19-048039 · doc4.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,000

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
September 03, 2019 Filed Sep 3, 2019 23:27 UTC
BERGER DAVID BEVP, Chief Legal & Compliance
SaleCommon Stock 2,000 $72.00 $144,000.00
Disclosure

SEC source: 0001209191-19-048039 · doc4.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,311

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2018.

Read SEC document
September 03, 2019 Filed Sep 3, 2019 23:27 UTC
BERGER DAVID BEVP, Chief Legal & Compliance
Exercise / conversionCommon Stock 2,000 $2.59 $5,180.00
Disclosure

SEC source: 0001209191-19-048039 · doc4.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,311

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
August 29, 2019 Filed Aug 30, 2019 20:19 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 80,000 $71.01 $5,680,800.00
Disclosure

SEC source: 0001209191-19-047825 · doc4.xml · nonDerivative · entry 2

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 891,750

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $71.00 and $71.135.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 23:56 UTC SaleCommon Stock 162 $71.00 $11,502.06
Disclosure

SEC source: 0000899243-19-022590 · doc4.xml · nonDerivative · entry 6

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 9,670

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $71.00 to $71.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi BioInvestments VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi BioInvestments VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi BioInvestments VIII, L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 23:56 UTC SaleCommon Stock 16,594 $71.00 $1,178,180.64
Disclosure

SEC source: 0000899243-19-022590 · doc4.xml · nonDerivative · entry 5

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 990,330

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $71.00 to $71.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi Ventures VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi Ventures VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi Ventures VIII, L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 23:56 UTC SaleCommon Stock 1,628 $70.42 $114,645.55
Disclosure

SEC source: 0000899243-19-022590 · doc4.xml · nonDerivative · entry 4

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 9,832

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi BioInvestments VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi BioInvestments VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi BioInvestments VIII, L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 23:56 UTC SaleCommon Stock 166,704 $70.42 $11,739,479.05
Disclosure

SEC source: 0000899243-19-022590 · doc4.xml · nonDerivative · entry 3

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,006,924

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi Ventures VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi Ventures VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi Ventures VIII, L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
August 28, 2019 Filed Aug 30, 2019 20:19 UTC
BLICKENSTAFF KIM DDirector · Executive Chairman
SaleCommon Stock 20,000 $70.77 $1,415,400.00
Disclosure

SEC source: 0001209191-19-047825 · doc4.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 971,750

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $70.49 and $70.95.

F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
August 27, 2019 Filed Aug 28, 2019 20:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionStock Option · Derivative 6,969 $0.00 Strike: $18.86 $0.00
Disclosure

SEC source: 0001209191-19-047601 · doc4.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 6,969 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
August 27, 2019 Filed Aug 28, 2019 20:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
SaleCommon Stock 6,969 $70.00 $487,830.00
Disclosure

SEC source: 0001209191-19-047601 · doc4.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,991

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018 and amended on May 16, 2019.

Read SEC document
August 27, 2019 Filed Aug 28, 2019 20:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 6,969 $18.86 $131,435.34
Disclosure

SEC source: 0001209191-19-047601 · doc4.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 27, 2019 Filed Aug 29, 2019 23:30 UTC
Allen DickDirector
GiftCommon Stock 3,000 $69.19 $207,570.00
Disclosure

SEC source: 0001209191-19-047772 · doc4.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 37,000

F1 · shares: The shares were given as a bona fide gift to Orange County Community Foundation (OCCF).

F2 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981.

Read SEC document
August 27, 2019 Filed Aug 29, 2019 23:56 UTC SaleCommon Stock 1,191 $70.10 $83,485.41
Disclosure

SEC source: 0000899243-19-022590 · doc4.xml · nonDerivative · entry 2

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 11,460

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi BioInvestments VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi BioInvestments VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi BioInvestments VIII, L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
August 27, 2019 Filed Aug 29, 2019 23:56 UTC SaleCommon Stock 122,018 $70.10 $8,553,083.54
Disclosure

SEC source: 0000899243-19-022590 · doc4.xml · nonDerivative · entry 1

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,173,628

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi Ventures VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi Ventures VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi Ventures VIII, L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
August 13, 2019 Filed Aug 14, 2019 20:06 UTC Exercise / conversionStock Option · Derivative 1,417 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001209191-19-045883 · doc4.xml · derivative · entry 3

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283

Underlying: Common Stock · 1,417 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
August 13, 2019 Filed Aug 14, 2019 20:06 UTC SaleCommon Stock 1,417 $63.03 $89,313.51
Disclosure

SEC source: 0001209191-19-045883 · doc4.xml · nonDerivative · entry 2

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,982

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $63.00 and $63.075.

Read SEC document
August 13, 2019 Filed Aug 14, 2019 20:06 UTC Exercise / conversionCommon Stock 1,417 $2.54 $3,599.18
Disclosure

SEC source: 0001209191-19-045883 · doc4.xml · nonDerivative · entry 1

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares were acquired due to the exercise of a previously awarded stock option. Each share converts upon exercise into one share of common stock.

Read SEC document
August 12, 2019 Filed Aug 13, 2019 20:53 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionStock Option · Derivative 15,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001209191-19-045769 · doc4.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
August 12, 2019 Filed Aug 13, 2019 20:53 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
SaleCommon Stock 15,000 $62.97 $944,550.00
Disclosure

SEC source: 0001209191-19-045769 · doc4.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,991

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2018 and amended on May 16, 2019.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.70 and $63.27.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.